Merck & Co Inc (LTS:0QAH)
$ 131.3 0 (0%) Market Cap: 260.35 Bil Enterprise Value: 283.89 Bil PE Ratio: 21.58 PB Ratio: 5.86 GF Score: 81/100

Merck & Co Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 07:40PM GMT
Release Date Price: $75.71 (+1.16%)
Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst

Okay. Good afternoon, everyone, and welcome to the first day of the afternoon session for the BofA Virtual Vegas Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here at BofA, and Olivia Brayer from my team is also on the line.

And we're thrilled to have Merck present this afternoon, and we have with us Frank Clyburn, who's Executive Vice President and Chief Commercial Officer, Frank you there?

Franklin K. Clyburn
Merck & Co., Inc. - Chief Commercial Officer & Executive VP

I am, Geoff. Can you hear me?

Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst

Yes. Perfect.

Franklin K. Clyburn
Merck & Co., Inc. - Chief Commercial Officer & Executive VP

Okay. Good.

Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst

And we also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot